NSEGeneral Updates23 Jun 2026 · 23 Jun 2026, 06:31 pm

General Updates

Bajaj Healthcare Limited · BAJAJHCARE

✦ AI SummaryDivestiture

Bajaj Healthcare Limited has approved the sale of an operational business unit located in Tarapur for up to ₹4.05 Crores, with completion expected by October 31, 2026. This unit contributed a minor 0.54% to the company's revenue and 0.74% to its net worth in the last financial year, indicating a negligible financial impact. The buyer, M/s Orchem Products, is an unrelated party, and the transaction is not considered a related party transaction.

Analysis Scores

Earnings Impact5/10
Growth Catalyst5/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk3/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Bajaj Healthcare Limited has informed the Exchange about General Updates

Attachments (1)

📄

BAJAJHCARE_23062026183057_Intimation.pdf

pdf

Download →
View document text
Ref: BHL/ STEX 12/ 2026-27 Date: June 23, 2026 BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers 5th Floor, Exchange Plaza, Dalal Street Bandra Kurla Complex Bandra (East) Mumbai-400001 Mumbai-400051 Scrip Code: 539872 Symbol: BAJAJHCARE Dear Sir/Madam, Subject: Intimation for Sale of Operational Business Unit pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Pursuant to Regulation 30 read with Schedule III of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015, we hereby inform you that the Board of Directors of the Company by way of a resolution passed by circulation on June 23, 2026, has approved the sale of the operational business unit of the Company situated at Plot No. N-178, MIDC, Tarapur Industrial Area, Tarapur, Boisar, Palghar-401 506, subject to the execution of definitive transaction documents. Further, we hereby confirm that none of the promoter/ promoter group/ group companies has any interest in the aforesaid entity and the transaction does not fall within the purview of Related Party Transactions. Pursuant to the provisions of the SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company's Code of Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading in Securities, the Trading Window for dealing in the securities of Bajaj Healthcare Limited shall remain closed for all Directors, Designated Persons and their immediate relatives from immediate effect till the expiry of 48 hours from the date of formal execution and signing of definitive agreements. The brief details, in accordance with the SEBI Listing Regulations read with SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 are enclosed as “Annexure-I”. You are requested to take the same on record. Thanking You, For and on behalf of Bajaj Healthcare Limited Monica Tanwar Company Secretary & Compliance Officer Encl: as above BAJAJ HEALTHCARE LIMITED Registered Office: 602-606, Bhoomi Velocity Infotech Park, Plot No: B-39, B-39A, B-39A/1, Road No. 23, Wagle Ind. Estate, Thane (West), Thane - 400604 Tel. : + 91 22 66177400/ 401; Fax : +91 22 66177458; E-mail : bajajhealth@bajajhealth.com CIN No. L99999MH1993PLC072892 Annexure-I Details required under the Listing Regulations read with SEBI Circular No. HO/49/14/14(7)2025- CFD-POD2/I/3762/2026 dated January 30, 2026 Sr. Particulars Details a) The amount and percentage of the turnover or Amount of the Revenue: 3.31 Crores revenue or income and net worth contributed by Percentage of Revenue: 0.54% such unit or division or undertaking or subsidiary or associate company of the listed entity during the last Amount of Net-Worth: 3.97 Crores financial year Percentage of Net-Worth: 0.74% b) Date on which the agreement for sale has been Not Applicable entered into c) The expected date of completion of sale/disposal The transaction is expected to be completed on or before 31st October 2026. d) Consideration received from such sale/disposal The consideration will be upto ₹4.05 Crores (Rupees Four Crores and Five Lakhs Only) e) Brief details of buyers and whether any of the buyers The Buyer is M/s Orchem Products which belong to the promoter/ promoter group/group does not belong to the Promoter/Promoter companies. If yes, details thereof Group/ Group companies and the transaction does not fall within the purview of Related Party Transactions. f) Whether the transaction would fall within related No party transactions? If yes, whether the same is done at “arm’s length” g) Whether the sale, lease or disposal of the Not Applicable. undertaking is outside Scheme of Arrangement? If yes, details of the same including compliance with The Sale of Unit does not fall under the regulation 37A of LODR Regulations. definition of an “Undertaking” as per the provisions of the Companies Act, 2013. h) Additionally, in case of a slump sale, indicative Not Applicable disclosures provided for amalgamation/merger, shall be disclosed by the listed entity with respect to such slump sale. BAJAJ HEALTHCARE LIMITED Registered Office: 602-606, Bhoomi Velocity Infotech Park, Plot No: B-39, B-39A, B-39A/1, Road No. 23, Wagle Ind. Estate, Thane (West), Thane - 400604 Tel. : + 91 22 66177400/ 401; Fax : +91 22 66177458; E-mail : bajajhealth@bajajhealth.com CIN No. L99999MH1993PLC072892